OLD Second National Bank of Aurora lowered its position in MetLife, Inc. (NYSE:MET – Free Report) by 1.1% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 52,259 shares of the financial services provider’s stock after selling 583 shares during the period. MetLife makes up approximately 0.9% of OLD Second National Bank of Aurora’s investment portfolio, making the stock its 29th largest holding. OLD Second National Bank of Aurora’s holdings in MetLife were worth $4,203,000 at the end of the most recent quarter.
A number of other large investors have also recently bought and sold shares of the company. Csenge Advisory Group boosted its position in MetLife by 1.0% in the first quarter. Csenge Advisory Group now owns 13,647 shares of the financial services provider’s stock valued at $1,096,000 after buying an additional 131 shares during the last quarter. Delta Investment Management LLC boosted its position in MetLife by 0.9% in the 1st quarter. Delta Investment Management LLC now owns 14,265 shares of the financial services provider’s stock worth $1,145,000 after purchasing an additional 133 shares in the last quarter. Glenview Trust co boosted its position in MetLife by 0.4% in the 1st quarter. Glenview Trust co now owns 38,333 shares of the financial services provider’s stock worth $3,078,000 after purchasing an additional 141 shares in the last quarter. Stock Yards Bank & Trust Co. boosted its position in MetLife by 2.5% in the 1st quarter. Stock Yards Bank & Trust Co. now owns 6,463 shares of the financial services provider’s stock worth $519,000 after purchasing an additional 159 shares in the last quarter. Finally, My Legacy Advisors LLC boosted its position in MetLife by 1.2% in the 2nd quarter. My Legacy Advisors LLC now owns 14,000 shares of the financial services provider’s stock worth $1,097,000 after purchasing an additional 164 shares in the last quarter. Hedge funds and other institutional investors own 94.99% of the company’s stock.
Analyst Ratings Changes
Several equities research analysts have commented on the company. JPMorgan Chase & Co. upped their price objective on MetLife from $86.00 to $95.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 8th. Wolfe Research upgraded MetLife to a “strong-buy” rating in a research report on Tuesday, September 16th. Cowen restated a “buy” rating on shares of MetLife in a research report on Friday, August 22nd. UBS Group decreased their target price on MetLife from $94.00 to $91.00 and set a “buy” rating on the stock in a research report on Thursday, August 7th. Finally, Barclays increased their target price on MetLife from $88.00 to $94.00 and gave the company an “overweight” rating in a research report on Monday, July 7th. One investment analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, MetLife currently has a consensus rating of “Moderate Buy” and an average price target of $94.64.
MetLife Stock Down 0.7%
Shares of MET opened at $81.34 on Friday. The stock has a fifty day simple moving average of $79.03 and a two-hundred day simple moving average of $78.20. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.57. The company has a market capitalization of $54.09 billion, a PE ratio of 13.79, a price-to-earnings-growth ratio of 0.74 and a beta of 0.86. MetLife, Inc. has a 52-week low of $65.21 and a 52-week high of $89.05.
MetLife (NYSE:MET – Get Free Report) last announced its quarterly earnings data on Wednesday, August 6th. The financial services provider reported $2.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.32 by ($0.30). The company had revenue of $17.34 billion during the quarter, compared to analysts’ expectations of $18.58 billion. MetLife had a net margin of 5.83% and a return on equity of 19.88%. The business’s quarterly revenue was down 2.7% compared to the same quarter last year. During the same quarter in the previous year, the business posted $2.28 EPS. As a group, equities analysts forecast that MetLife, Inc. will post 9.65 EPS for the current year.
MetLife Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 9th. Investors of record on Tuesday, August 5th were paid a dividend of $0.5675 per share. The ex-dividend date was Tuesday, August 5th. This represents a $2.27 annualized dividend and a yield of 2.8%. MetLife’s payout ratio is presently 38.47%.
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Read More
- Five stocks we like better than MetLife
- Why is the Ex-Dividend Date Significant to Investors?
- General Dynamics Hits New Highs: Why It Might Keep Climbing
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Nike’s Turnaround: If the Shoe Fits, Buy It!
- Most Volatile Stocks, What Investors Need to Know
- NVIDIA Breaks Out to New Highs: What Comes Next?
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.